FDA approves Pfizer's drug for rare blood cancer By: Reuters: Company News August 17, 2017 at 13:48 PM EDT Aug 17 (Reuters) - The U.S. Food and Drug Administration (FDA) said on Thursday it approved Pfizer Inc's treatment for a rare type of blood cancer. Read More >> Related Stocks: Pfizer